The global intravenous (IV) solutions market is expected to witness steady growth over the forecast period. Factors such as an aging population, rising prevalence of chronic diseases, and increasing demand for parenteral nutrition are expected to drive market growth. In addition, the COVID-19 pandemic has further increased demand for IV solutions in the treatment of critically ill patients. However, the market faces challenges such as the high cost of IV solutions, risks associated with improper use, and regulatory issues. Furthermore, the market is highly competitive, with several established players as well as new entrants vying for market share. Technological advancements and strategic collaborations are expected to drive innovation and growth in the market.
Global Intravenous Solutions Market size was valued at US$ 9,907.8 Million in 2022 and is expected to witness a CAGR of 6.1% over the forecast period (2022 – 2030).
Key Companies in the Intravenous Solutions Industry:
1. Baxter International Inc.
Baxter International Inc. is a global healthcare company that develops and manufactures medical devices, pharmaceuticals, and biotechnology products. The company was founded in 1931 and is headquartered in Deerfield, Illinois, United States. It operates in more than 100 countries worldwide. In February, 2023 Miromatrix Medical Inc. and Baxter International Inc. announced a collaborative research agreement to help support additional treatment options for patients with acute liver failure (ALF) in need of organ support therapies.
2. ICU Medical Inc.
ICU Medical Inc. is a San Clemente, California-based company that specializes in the development, manufacture, and sale of medical devices used in infusion therapy, critical care, and oncology applications. It was founded in 1984 and currently operates in more than 50 countries. In September, 2021 ICU Medical, Inc. and Smiths Group plc announced that ICU Medical has committed1 to acquire the Smiths Medical division in a transaction that is superior to the existing proposed sale of Smiths Medical to Trulli Bidco Limited.
3. B. Braun Melsungen AG
B. Braun Melsungen AG is a German medical and pharmaceutical company that produces medical devices and pharmaceutical products. The company was founded in 1839 and is headquartered in Melsungen, Germany. It operates in more than 60 countries worldwide. In March, 2022 B. Braun acquires Intermedt Medizin & Technik GmbH, a specialist in the preparation of dialysis concentrates
4. Grifols, S.A.
Grifols, S.A. is a Spanish multinational pharmaceutical and chemical company that produces plasma-derived products, vaccines, and hospital supplies. The company was founded in 1909 and is headquartered in Barcelona, Spain. It operates in more than 100 countries worldwide. Grifols, S.A. announced on December, 2021, that it has received approval from the US Food and Drug Administration (FDA) for Xembify, a new 20% immunoglobulin solution for intravenous infusion.
5. Fresenius Kabi USA, LLC
Fresenius Kabi USA, LLC is a subsidiary of Fresenius Kabi AG, a German healthcare company that specializes in infusion therapy and clinical nutrition. The company was founded in 1912 and is headquartered in Lake Zurich, Illinois, United States. It operates in more than 190 countries worldwide.
6. Vifor Pharma Management Ltd
Vifor Pharma Management Ltd is a Swiss pharmaceutical company founded in 1872, headquartered in Zurich, Switzerland. The company is primarily engaged in the research, development, and marketing of treatments for renal diseases, iron deficiency, and other medical conditions. It operates in over 100 countries worldwide. Vifor Pharma Management Ltd announced on August, 2021, that it has launched Venofer (iron sucrose injection) in Canada, a treatment option for iron deficiency anemia in adult patients with chronic kidney disease.
7. JW Life Science
JW Life Science is a South Korean medical company founded in 1945, headquartered in Seoul, South Korea. The company offers a range of products related to medical devices, pharmaceuticals, and consumer healthcare. It operates in over 20 countries worldwide.
8. Amanta Healthcare
Amanta Healthcare is an Indian pharmaceutical company founded in 2004, headquartered in Ahmedabad, India. The company is primarily engaged in the research, development, and production of generic drugs and medical devices. It operates in over 40 countries worldwide.
9. Axa Parenterals Ltd
Axa Parenterals Ltd is an Indian pharmaceutical company founded in 1990, headquartered in Bangalore, India. The company offers a range of sterile injectable products for use in hospitals and clinics. It operates in over 30 countries worldwide. Axa Parenterals Ltd announced on June, 2021, that it has launched Ringer Lactate IV Solution in India, a treatment option for patients with fluid and electrolyte imbalances.
10. Salius Pharma Private Limited
Salius Pharma Private Limited is an Indian pharmaceutical company founded in 2011, headquartered in Mumbai, India. The company is primarily engaged in the research, development, and production of generic drugs for various medical conditions. It operates in over 10 countries worldwide.
11. Pfizer Inc.
Pfizer Inc. is an American multinational pharmaceutical corporation founded in 1849, headquartered in New York City, USA. The company is primarily engaged in the research, development, and production of prescription drugs for various medical conditions. It operates in over 100 countries worldwide. In March, 2023 Pfizer Inc. and BioNTech SE announced that the U.S. Food and Drug Administration (FDA) granted emergency use authorization (EUA) to provide a single booster dose of the companies’ Omicron BA.4/BA.5-adapted bivalent COVID-19 vaccine in children 6 months through 4 years of age (also referred to as under 5 years of age) at least 2 months after completion of primary vaccination with three doses of the Pfizer-BioNTech COVID-19 Original Vaccine.
12. Otsuka Pharmaceutical Co., Ltd
Otsuka Pharmaceutical Co., Ltd is a Japanese pharmaceutical company founded in 1964, headquartered in Tokyo, Japan. The company is primarily engaged in the research, development, and production of drugs for various medical conditions, including neurological and psychiatric disorders. It operates in over 30 countries worldwide.
13. Ajinomoto Co., Inc.
Ajinomoto Co., Inc. is a Japanese food and biotechnology company founded in 1909, headquartered in Tokyo, Japan. The company is primarily engaged in the research, development, and production of food products, amino acids, and pharmaceuticals. It operates in over 30 countries worldwide. Ajinomoto Co., Inc. announced on February, 2021, that it has launched a new amino acid solution product, AminoIndex Injection 18, in Japan, a treatment option for patients with metabolic disorders.
*Definition- Intravenous solutions are sterile fluids administered directly into a patient's vein through a needle or catheter. These solutions contain a variety of substances, such as water, electrolytes, and nutrients, and are used to provide hydration, medication, or nutrition to patients.
